Recent interest in exploiting the PD-1:PD-L regulatory axis for treatment of chronic viral infections, cancer, and autoimmunity is supported by numerous mouse, non-human primate and human studies [18,19,20,21]. This evidence concerns the gene PDCD1 and Autoimmunity.